Literature DB >> 10196008

Blood pressure, antihypertensive medication, and atherosclerotic renal artery stenosis.

M J Tullis1, M T Caps, R E Zierler, R O Bergelin, N Polissar, K Cantwell-Gab, R C Davidson, D E Strandness.   

Abstract

The relationship between atherosclerotic renal artery stenosis (ARAS) and blood pressure control remains poorly understood. Duplex ultrasonography is a noninvasive method for detecting and grading ARAS. The purpose of this study was to characterize the relationship between the degree of ARAS, levels of blood pressure, and control of blood pressure with antihypertensive medication. A cross-sectional analysis was performed on 139 patients with ARAS. All patients had at least one diseased renal artery by duplex ultrasound. Renal arteries were classified as normal, less than 60% stenosis, or 60% or greater (high-grade) stenosis. Data regarding blood pressure, coexisting risk factors, and medications were collected. The extent of ARAS was significantly associated with progressive elevation of the systolic blood pressure, whereas the diastolic component was elevated in the case of unilateral high-grade stenosis: no high-grade stenoses, 153 +/- 22/81 +/- 10 mm Hg; unilateral high-grade stenosis, 162 +/- 22/86 +/- 9 mm Hg; and bilateral high-grade stenoses, 174 +/- 27/82 +/- 9 mm Hg (P = 0.002 systolic; P = 0.02 diastolic). Eighty-two percent of the patients were taking known antihypertensive medications. Angiotensin-converting enzyme inhibitor (ACEI) usage versus nonusage was associated with a significantly lower systolic (157 +/- 27 v 169 +/- 22 mm Hg; P = 0.03) and diastolic (79 +/- 9 v 85 +/- 9 mm Hg; P = 0.001) blood pressure. The effect of ACEI usage was observed in patients with high-grade ARAS. None of the other classes of antihypertensive medications were associated with significantly lower blood pressure. In patients with ARAS, blood pressure levels were correlated with the severity of renal artery disease. Patients taking ACEIs had significantly lower blood pressures, and the effect of ACEI usage was strongest among patients with unilateral ARAS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196008     DOI: 10.1016/s0272-6386(99)70218-0

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Renal failure in atherosclerotic renovascular disease: pathogenesis, diagnosis, and intervention.

Authors:  R G Woolfson
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

2.  Long-term safety and efficacy of renin-angiotensin blockade in atherosclerotic renal artery stenosis.

Authors:  Sofia Sofroniadou; Theodoros Kassimatis; Rajaventhan Srirajaskanthan; John Reidy; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

3.  Juvenile linear scleroderma with unique forms of renal involvement.

Authors:  Belde Kasap; Alper Soylu; Mehmet Türkmen; Yiğit Göktay; Sülen Sarioğlu; Can Oztürk; Ozgür Kasapçopur; Salih Kavukcu
Journal:  Pediatr Nephrol       Date:  2009-05-28       Impact factor: 3.714

Review 4.  Blockade of the renin-angiotensin system in hypertensive patients with atherosclerotic renal artery stenosis.

Authors:  Faical Jarraya; Menno Pruijm; Gregoire Wuerzner; Michel Burnier
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 5.  Renal Artery Stenosis: Optimal Therapy and Indications for Revascularization.

Authors:  Sandeep M Patel; Jun Li; Sahil A Parikh
Journal:  Curr Cardiol Rep       Date:  2015-09       Impact factor: 2.931

6.  Successful percutaneous transluminal angioplasty for the treatment of renovascular hypertension with an atrophic kidney.

Authors:  Keisuke Maruyama; Junko Chinda; Maki Kabara; Naoki Nakagawa; Takayuki Fujino; Toshiharu Takeuchi; Naoyuki Hasebe
Journal:  Heart Vessels       Date:  2014-01-03       Impact factor: 2.037

7.  Fibromuscular dysplasia in an adult male as a cause of renal artery stenosis and secondary hypertension treated with renal artery stenting.

Authors:  K C Bishal; Rabi Malla; Chandra Mani Adhikari; Binay Rauniyar; Deepak Limbu
Journal:  Egypt Heart J       Date:  2016-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.